Funder
Taiho Pharmaceutical Co., Ltd.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol. 1, 505–527 (2015).
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cervical cancer, version 1. 2017
https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf
. Accessed 16 May 2017.
3. Marth, C. et al. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 28, iv72–iv83 (2017).
4. Katsumata, N. et al. Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer. Ann. Oncol. 22, 1353–1357 (2011).
5. Koizumi, W. et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 9, 215–221 (2008).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献